BEST LAUNCH

The “Knolling” Campaign for Bronchitol

Bronchitol is an inhaled treatment that helps break up the mucus characteristic in the lungs of patients with Cystic Fibrosis. It’s administered via a small, portable 2-inch-tall inhaler, and can be administered in about 5 minutes from anywhere—which represents an upgrade from current treatments which require a bulky nebulizer and 3 times as long to administer.

 The target is the active patient over 18—young college students finally out on their own, and other adults with busy, on-the-go lives. The Knolling campaign simply communicates the core benefit of Bronchitol to both physicians and patients: that the discrete, portable inhaler that takes just minutes to use can easily fit into patients’ lives.